Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.

Bölling T, Dirksen U, Ranft A, Ernst I, Jürgens H, Willich N

Research article (journal)

Details about the publication

JournalStrahlentherapie und Onkologie
Volume185 Suppl
Page range21-22
StatusPublished
Release year2009
Language in which the publication is writtenEnglish
KeywordsGermany; Randomized Controlled Trials as Topic; Combined Modality Therapy; Spinal Cord; Multicenter Studies as Topic; Antineoplastic Combined Chemotherapy Protocols; Registries; Adolescent; Radiation Injuries; Retrospective Studies; Melphalan; Ifosfamide; Survivors; Sarcoma Ewing's; Child; Vincristine; Bone Neoplasms; Dactinomycin; Humans; Radiotherapy Adjuvant; Intestines; Lung; Cross-Sectional Studies; Busulfan; Risk Factors; Radiotherapy Dosage; Dose-Response Relationship Drug; Chemotherapy Adjuvant; Germany; Randomized Controlled Trials as Topic; Combined Modality Therapy; Spinal Cord; Multicenter Studies as Topic; Antineoplastic Combined Chemotherapy Protocols; Registries; Adolescent; Radiation Injuries; Retrospective Studies; Melphalan; Ifosfamide; Survivors; Sarcoma Ewing's; Child; Vincristine; Bone Neoplasms; Dactinomycin; Humans; Radiotherapy Adjuvant; Intestines; Lung; Cross-Sectional Studies; Busulfan; Risk Factors; Radiotherapy Dosage; Dose-Response Relationship Drug; Chemotherapy Adjuvant

Authors from the University of Münster

Bölling, Tobias
Ernst, Iris
Willich, Normann